1. Home
  2. RAMP vs MLTX Comparison

RAMP vs MLTX Comparison

Compare RAMP & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiveRamp Holdings Inc.

RAMP

LiveRamp Holdings Inc.

HOLD

Current Price

$37.71

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$18.66

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAMP
MLTX
Founded
2018
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
RAMP
MLTX
Price
$37.71
$18.66
Analyst Decision
Buy
Buy
Analyst Count
5
12
Target Price
$35.60
$27.50
AVG Volume (30 Days)
1.3M
1.3M
Earning Date
05-20-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
22500.00
N/A
EPS
2.24
N/A
Revenue
$812,940,000.00
N/A
Revenue This Year
$11.18
N/A
Revenue Next Year
$9.09
N/A
P/E Ratio
$16.84
N/A
Revenue Growth
9.03
N/A
52 Week Low
$21.71
$5.95
52 Week High
$37.92
$62.75

Technical Indicators

Market Signals
Indicator
RAMP
MLTX
Relative Strength Index (RSI) 68.61 49.10
Support Level $37.25 $15.54
Resistance Level $37.92 $19.24
Average True Range (ATR) 0.19 1.12
MACD -0.24 -0.11
Stochastic Oscillator 78.69 22.78

Price Performance

Historical Comparison
RAMP
MLTX

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: